Prioritize quality sleep Research analyzing over 40,000 social media posts found that sleep disturbances and insomnia were commonly discussed topics among people taking GLP-1 medications like tirzepatide, semaglutide, and other similar drugs
The company has not published efficacy data and did not respond to a request for information
Assessment timelines matter significantly
In SUSTAIN-6, patients on semaglutide experienced an average 4 mmHg greater systolic drop than placebo after 30 weeks, independent of weight loss (see the SUSTAIN-6 trial publication )
Regular check-ins help track progress, manage side effects, and adjust care as needed
Amphetamine lowers neuropeptide Y, a compound that drives hunger, and activates pathways that reduce food-seeking behavior